Clearmind Medicine Inc.
- CMND
- NASDAQ
- Biotechnology
- Psychedelic Therapeutics
- Mental Health/Addiction
$6.00
Today −4.15%Quote Oct 19, 2026, 08:00 PM UTC
−6.25%over the last month
Max drawdown −15.9%From 1-month high −11.8%3 months −54.3%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Clearmind Medicine
Clearmind Medicine Inc. is a pre-clinical biopharmaceutical company dedicated to pioneering the development of novel psychedelic-based treatments. Their primary goal is to address a variety of mental health and addiction challenges that currently lack adequate solutions.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
4
Founded
2017
Market value
$948,456
Quote Oct 19
Floor
$5.82
3.0% below price
Resistance
$6.04
0.7% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about CMNDPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free